Hot Topics in Primary Care: Demystifying the Differences: Follow-on Biologics, Biosimilars, and Generics.

Wright, Eugene E; Blevins, Thomas C; Reed, Beverly; Pollom, Roy Daniel

Wright, Eugene E; Blevins, Thomas C; Reed, Beverly; Pollom, Roy Daniel.

Affiliation

Wright EE; Consulting Associate, Department of Medicine and Department of Community and Family Medicine, Southern Regional Area Health Education Center, Duke University School of Medicine, Durham, NC, USA.
Blevins TC; Texas Diabetes and Endocrinology, Austin, TX, USA.
Reed B; Eli Lilly and Company, Indianapolis, IN, USA.
Pollom RD; Eli Lilly and Company, Indianapolis, IN, USA.

J Fam Pract ; 66(4 Suppl): S22-S27, 2017 Apr.

Article in En | MEDLINE | ID: mdl-28375404

Subject(s)

Biosimilar Pharmaceuticals/classification; Biosimilar Pharmaceuticals/standards; Drug Approval/methods; Drugs, Generic/classification; Drugs, Generic/standards; Guidelines as Topic; Humans; Primary Health Care; United States; United States Food and Drug Administration

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Generic / Guidelines as Topic / Drug Approval / Biosimilar Pharmaceuticals Type of study: Guideline Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Fam Pract Year: 2017 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links